Target PharmaSolutions

Target PharmaSolutions, Inc. is a privately-held healthcare data company based in Durham, North Carolina. The company employs 9 people and reports annual revenue of $20 million. Target PharmaSolutions provides regulatory grade, real-world clinical data and evidence to support strategic drug development and commercialization. Their turnkey solution allows partners to quickly build disease communities through longitudinal, observational real-world data registries. The company leverages its established site relationships and proven framework to deliver quality data insights in a timely manner. Target PharmaSolutions specializes in the generation of real-world evidence for seven specific disease communities: nonalcoholic steatohepatitis (NASH), hepatocellular carcinoma (HCC), inflammatory bowel disease (IBD), primary biliary cholangitis (PBC), immune-mediated inflammatory skin conditions (DERM), chronic hepatitis B (HBV), and asthma. For more information about Target PharmaSolutions, please visit their website at targetpharmasolutions.com.